SCHEMBL687688

SCHEMBL687688

CCCOc1cccc(Cl)c1Cn1cc(C)c(O)c(NC(=O)N[C@@H](CC(=O)O)c2cccc(OCC)c2)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.37
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
FFAR1 O14842 1/20 0.34
MAPT P10636 2/20 0.33
RXFP1 Q9HBX9 2/20 0.33
LMNA P02545 1/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP3A4 P08684 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
PTGER3 P43115 2/20 0.32
CTSA P10619 3/20 0.32
PPARG P37231 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
P2RX3 P56373 1/20 0.32
CYP1A2 P05177 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688507 0.97 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1KDM4EFFAR1MAPT
SCHEMBL686989 0.96 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1KDM4EFFAR1MAPT
SCHEMBL688501 0.93 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1KDM4EFFAR1LMNA
SCHEMBL688946 0.92 SMN1; SMN2 (0.34) SMN1; SMN2ALDH1A1KDM4EFFAR1MAPT
SCHEMBL686996 0.92 P2RX3 (0.35) SMN1; SMN2ALDH1A1KDM4EFFAR1MAPT
SCHEMBL693144 0.91 KDM4E (0.37) SMN1; SMN2ALDH1A1KDM4EFFAR1RXFP1
SCHEMBL687802 0.91 CTSA (0.34) SMN1; SMN2ALDH1A1KDM4EFFAR1LMNA
SCHEMBL687119 0.91 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1KDM4EFFAR1MAPT
SCHEMBL687907 0.90 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1KDM4EFFAR1MAPT
SCHEMBL688286 0.90 SMN1; SMN2 (0.39) SMN1; SMN2ALDH1A1KDM4EMAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed